Enhanced, Simplified Glucose Sensors: Long‐Term Clinical Application of Wearable Artificial Endocrine Pancreas
Authors:
- 1 January 1998
- journal article
- conference paper
- Published by Wiley in Artificial Organs
- Vol. 22 (1) , 32-42
Abstract
At present, 2 major problems should be solved before long‐term application of the wearable artificial endocrine pancreas, the development of a reliable and stable glucose monitoring system and the development of a subcutaneous insulin infusion algorithm. With either a miniaturized extracorporeal glucose monitoring system based on microdialysis sampling method or a ferrocene‐mediated needle‐type glucose sensor covered with highly biocompatible membrane, poly(2‐methacryloyloxyethyl phosphorylcholine‐co‐n‐butyl methacrylate) (poly[MPC‐co‐BMA]) membrane, subcutaneous glucose concentrations could be monitored for 7 days without any in vivo calibrations, followed by 14 days with one point calibration. Considering the management and safety of the insulin delivery route, subcutaneous insulin infusion is obligatory. With the subcutaneous insulin infusion algorithm using a short acting insulin analogue (Insulin Lispro), near physiological glycemic control could be established in diabetic patients without showing any delayed hyperinsulinemia or hypoglycemia. The wearable artificial endocrine pancreas is now recognized as an excellent therapeutic tool for regulating blood glucose excursions physiologically in ambulatory diabetic patients on a long‐term basis.Keywords
This publication has 13 references indexed in Scilit:
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- Effect of the Insulin Analogue [LYS(B28),PRO(B29)] on Blood Glucose ControlHormone and Metabolic Research, 1994
- Development of a Miniaturized Glucose Monitoring System by Combining a Needle-Type Glucose Sensor With Microdialysis Sampling Method: Long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patientsDiabetes Care, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Hemocompatibility of human whole blood on polymers with a phospholipid polar group and its mechanismJournal of Biomedical Materials Research, 1992
- Reduced thrombogenicity of polymers having phospholipid polar groupsJournal of Biomedical Materials Research, 1990
- Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic responseDiabetes, 1984
- A mathematical insulin-secretion model and its validation in isolated rat pancreatic islets perifusionComputers and Biomedical Research, 1984
- Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreasDiabetologia, 1983
- WEARABLE ARTIFICIAL ENDOCRINE PANCREAS WITH NEEDLE-TYPE GLUCOSE SENSORThe Lancet, 1982